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Coronary heart disease and stroke rank among the leading causes of death in the industrialized world 1 , and a substantial genetic component underlies both of these outcomes. These clinical events are often preceded by the development of subclinical atherosclerosis, typically a thickening of the artery wall caused by deposition of cholesterolrich material in the arteries that supply blood to the major organs 2 . Generalized atherosclerosis results from endothelial dysfunction, inflammation, abnormalities in lipoprotein metabolism 3 , coagulation and fibrinolysis 4 .
Measures of subclinical atherosclerosis, which is disease that occurs before symptoms are noted, are predictive of incident clinical events and can be detected non-invasively and with reasonable precision in population samples using high-resolution ultrasound techniques. Both carotid intima media thickness (cIMT) and plaque, which reflect a thickening of the carotid artery wall or the presence of large irregular arterial wall deposits, respectively, are established measures of subclinical atherosclerotic disease. Although there may be variation in carotid ultrasound measurement techniques, multiple independent studies have established consistent association of carotid phenotypes with coronary events and stroke in prospective studies of young, middle-aged and older adults 5, 6 , and recent consensus prevention guidelines cite cIMT as a potentially useful measure for prediction of these events 7 . Although there is a correlation between common cIMT and carotid plaque, common cIMT reflects carotid artery wall thickening that may result from multiple vascular etiologies including hypertension and atherosclerosis, whereas carotid plaque is an indicator of the discrete occurrence of carotid atherosclerosis. Several recent studies have provided evidence that carotid plaque is a better predictor of future cardiovascular disease risk than common cIMT [8] [9] [10] .
Numerous family studies have established consistent evidence for moderate heritabilities for common cIMT, internal cIMT and carotid plaque ( Supplementary Table 1 ). However, candidate gene studies have not found consistent associations between SNPs and cIMT 11 , and genome-wide linkage scans completed to date have revealed only suggestive regions for common cIMT 12, 13 . We performed a genome-wide association study (GWAS) of three measures of subclinical carotid atherosclerosis-common cIMT, internal cIMT and plaque-in a sample of up to 31,211 participants from nine population-based studies that performed genome-wide genotyping with commercial SNP arrays and imputed the samples to the approximately 2.5 million autosomal SNPs in the phase II HapMap European CEU reference panel. In addition, we followed up our discovery findings in a second stage that included 11,273 participants from seven independent studies.
RESULTS
The cross-sectional discovery genome-wide analysis of carotid artery phenotypes included 31,211 participants from nine community-based studies whose mean age ranged from 44-76 years. Characteristics of the samples are presented in the Supplementary Note. In the studies in which all three carotid measures were available, the correlations between common cIMT and plaque ranged from 0.27 to 0.39, and the correlations between common cIMT and internal cIMT ranged from 0.36 to 0.67 (Supplementary Table 2 ).
The a priori threshold for genome-wide significance used was P = 5 × 10 −8 , and 5 × 10 −8 < P < 4 × 10 −7 , corresponding to not more than one expected false positive finding over 2.5 million tests, was considered suggestive evidence for association in our analyses.
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque Carotid intima media thickness (cIMT) and plaque determined by ultrasonography are established measures of subclinical atherosclerosis that each predicts future cardiovascular disease events. We conducted a meta-analysis of genome-wide association data in 31,211 participants of European ancestry from nine large studies in the setting of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. We then sought additional evidence to support our findings among 11,273 individuals using data from seven additional studies. In the combined meta-analysis, we identified three genomic regions associated with common carotid intima media thickness and two different regions associated with the presence of carotid plaque (P < 5 × 10 −8 ). The associated SNPs mapped in or near genes related to cellular signaling, lipid metabolism and blood pressure homeostasis, and two of the regions were associated with coronary artery disease (P < 0.006) in the Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) consortium. Our findings may provide new insight into pathways leading to subclinical atherosclerosis and subsequent cardiovascular events.
A full list of authors and affiliations appears at the end of the paper.
A r t i c l e s Figure 1a provides a plot of -log 10 P for the associations of the approximately 2.5 million SNPs with common cIMT by chromosome and position for the meta-analysis of the nine discovery studies. The P values from the meta-analysis of plaque (n = 25,179 participants) and internal cIMT (n = 10,962) are presented according to their genomic positions (shown in Fig. 1b and Supplementary Fig. 1, respectively) . Overall, from the discovery meta-analysis of common cIMT and plaque, we carried forward three genome-wide significant SNPs and five suggestive SNPs to the second stage. Our second stage included 11,273 participants from seven community-based studies, six of which provided results for common cIMT (total N = 10,403) and three of which provided results for plaque (N = 6,013). Characteristics of the participants in these studies are shown in the Supplementary Note. Table 1 presents the genome-wide significant association results for the discovery, second-stage and combined meta-analyses for common cIMT and plaque. We show the discovery GWAS results for the 100-kb regions surrounding the signal SNPs for common cIMT and plaque along with the recombination rates and the known genes in that region ( Figs. 2  and 3) . We also show the study-specific findings from the combined metaanalyses of common cIMT and plaque ( Figs. 4 and 5) . Results for the suggestive loci in the meta-analyses of common cIMT and plaque are shown in Supplementary Table 3 and Supplementary Figures 2-5 .
Common cIMT
For common cIMT, three independent loci achieved our genome-wide significance threshold (P < 5 × 10 −8 ) in the combined meta-analysis. The strongest association was for rs11781551, found on 8q24 approximately 385 kb from ZHX2, where the A allele (allele frequency (AF) = 0.48) was associated with lower common cIMT (β, expressing the mean difference in ln(cIMT) per copy of the modeled allele, = −0.0078, P = 2.4 × 10 −11 ), meaning there is a 0.8% lower mean common cIMT per copy of the A allele. The second association was for rs445925, located 2.3 kb from APOC1 on 19q13, a region that also includes APOE, APOC2 and APOC4. The G allele (AF = 0.11) was associated with lower common cIMT (β = -0.0156, P = 1.7 × 10 −8 ). The third association was for rs6601530, located within PINX1 on 8q23.1. Each copy of the G allele (AF = 0.45) was associated with higher common cIMT (β = 0.0078, P = 1.7 × 10 −8 ). We also identified a suggestive locus, marked by rs4712972 near SLC17A4 on 6p22, where the A allele was associated with higher common cIMT (β = 0.0099, P = 7.8 × 10 −8 ).
Although our genome-wide significant and suggestive SNPs from the combined meta-analyses for common cIMT explained a small proportion of the trait variance (up to 1.1%), we further constructed an additive genetic risk score (0-8 alleles) comprised of the number of common cIMT risk alleles at the four loci. In the discovery samples, the additive risk score showed graded increasing association with common cIMT across all studies, with an average increase of 9.5% in common cIMT from the lowest (0-2) to the highest (6-8) risk category ( Supplementary Fig. 6 ).
Plaque
In the analysis of carotid artery plaque, two independent loci achieved the genome-wide significance threshold (P < 5 × 10 −8 ) in the combined meta-analysis. We observed the most significant signal for rs17398575, situated 96.5 kb from PIK3CG on 7q22. Per copy of the T allele (AF = 0.25), we observed an 18% increased odds of the presence of plaque (P = 2.3 × 10 −12 ). The second signal was centered at rs1878406, located 8.5 kb from EDNRA on 4q31. Each copy of the T allele (AF = 0.13) was associated with a 22% increased odds of the presence of plaque (P = 6.9 × 10 −12 ). Furthermore, two SNPs showed suggestive evidence for association in our combined meta-analysis. The first suggestive locus was rs17045031 on 3p13, where each copy The alleles listed are the coded (named first) and non-coded allele. Chr., chromosome; AF, the allele frequency for the coded allele, which is an average weighted by study size; OR, odds ratio; CI, confidence interval; N, effective sample size calculated by taking the sum of each study's sample size multiplied by the SNP's imputation quality. Where more than one SNP at a locus surpassed our P value threshold, we present the SNP with the lowest P value. 9 4 2 VOLUME 43 | NUMBER 10 | OCTOBER 2011 Nature GeNetics A r t i c l e s of the A allele was associated with a decreased odds of the presence of plaque (P = 1.0 × 10 −7 ). Our second suggestive locus was rs6511720, near LDLR on 19p13. Per copy of the T allele, we observed a decreased odds of the presence of plaque (P = 3.8 × 10 −7 ). For both cIMT and plaque, secondary discovery genome-wide meta-analyses conditioned on the genome-wide significant and suggestive SNPs from the combined meta-analyses did not reveal any additional associations.
Internal cIMT
No SNP achieved our significance threshold for follow up in the discovery analyses of internal cIMT. Results for internal cIMT SNPs with P < 1.0 × 10 −5 are shown in Supplementary Table 4 . Table 5 shows the results for the genome-wide significant and suggestive SNPs from our combined meta-analyses for common cIMT and plaque across the three carotid phenotypes. The directions of association were generally consistent, and three SNPs, rs445925 (APOC1) from the common cIMT analysis, and rs17398575 (PIK3CG) and rsrs1878406 (EDNRA) from the plaque analysis, were associated with all three phenotypes (P < 0.05/8/2 = 0.003) in cross-phenotype comparisons.
Cross-phenotype comparisons Supplementary

Associations with coronary artery disease
We investigated the genome-wide significant and suggestive SNPs from our combined meta-analyses for common cIMT and plaque for their potential associations with coronary artery disease (CAD) in the CARDIoGRAM consortium ( Table 2) . Two SNPs from our plaque analysis had a P value for association with CAD less than 0.006 (0.05/8 tests). The first SNP was rs6511720 near LDLR, where the G allele was associated with both higher plaque risk in our study and higher CAD risk (P = 0.0002), and the second SNP was rs1878406 near EDNRA, where the C allele was associated with lower risk of plaque and lower risk of CAD (P = 2 × 10 −6 ). One SNP from the common cIMT analysis, rs445925 near APOC1, showed a suggestive association with CAD, with the same allele (A) being associated with higher common cIMT and higher CAD risk (P = 0.02). Another SNP identified in the plaque analysis, rs17045031 near LRIG1, showed a suggestive association with CAD, with the G allele being associated with both lower odds of plaque and lower risk of CAD (P = 0.04).
Conversely, none of SNPs reported to be associated with coronary artery disease in the CARDIoGRAM consortium 14 had a significant association (P < 0.00072, using a conservative Bonferroni correction for 23 tests across three phenotypes) in our discovery meta-analyses of common cIMT, internal cIMT or plaque ( Supplementary Table 6 ).
DISCUSSION
In this meta-analysis of GWAS data from nine studies of common cIMT and seven studies of plaque, we identified genome-wide significant associations between three regions and common cIMT and between two regions and the presence of carotid plaque in over 40,000 participants of European ancestry. Notably, EDNRA, one of our genome-wide significant regions in the combined meta-analysis of plaque, was related to multiple carotid phenotypes and was also associated with coronary artery diseases in the recent large metaanalysis by the CARDIoGRAM consortium.
Three SNPs emerged as genome-wide significant from our combined meta-analysis of common cIMT. The strongest association, on chromosome 8 (rs11781551), is an intergenic SNP located 385 kb from ZHX2. Members of the zinc fingers and homeobox gene families encode nuclear homodimeric transcriptional repressors that interact with the A subunit of nuclear factor-Y (NF-YA) and contain two C2H2-type zinc fingers and five homeobox DNA-binding domains. Little information about these proteins exists regarding cardiovascular disease or population studies. Although this region has been of interest for its role in neurological genetics because of APOE, APOC1 has also been a frequent candidate gene for cardiovascular disease traits 15 . Although some previous studies have found associations of variation at the APOE locus and common cIMT 16 , among four of our discovery studies that had independently measured the APOE ε variants, the correlation between rs445925 and the ε4 allele was less than 0.05. Further, models that included both the APOE ε4 and the APOC1 variant indicated that APOE was not associated with common cIMT in these studies (Supplementary Table 7) , whereas the APOC1 variant still showed a significant association with common cIMT. Although APOE variants have been implicated in cases of familial dyslipidemia and premature atherosclerosis and, in recent GWAS, with variation in multiple lipoprotein measures 17 , our results suggest that APOC1 is the primary variant of interest for carotid traits.
The third association (rs6601530) was located in an intron of PINX1, encoding Pin2-interacting protein 1. This protein, a telomerase inhibitor 18 that plays a role in chromosomal segregation in mitosis 19 , has been investigated in relation to cancers but was not considered a candidate gene for cardiovascular phenotypes.
The region on chromosome 6 marked by rs4712972, which includes SLC17A4, SLC17A1 and SLC17A3, showed suggestive evidence for association with common cIMT in our combined meta-analysis. This region may merit further investigation, as recent genomewide association studies have implicated this region with uric acid levels 20, 21 . Although high uric acid levels have been associated with cardiovascular disease and all-cause mortality 22 , their contribution to atherosclerotic vascular disease remains controversial 23 .
For plaque, two regions were genome-wide significant in our combined meta-analysis. The first region was within 100 kb of PIK3CG, which encodes one of the pi3/pi4-kinase family of proteins. These proteins are important modulators of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays the important role of endothelin in maintenance of the structural and functional integrity of epithelia. The fact that this region was reported as a top hit in a recent GWAS of both platelet volume 24 and aggregation 25 suggests pleiotropy and highlights the interconnectedness of multiple cardiometabolic traits.
The second genome-wide significant region was near EDNRA. Because of the role of endothelin as a potent vasoconstrictor, the endothelin receptor, type A is a target for pharmacologic treatments to reduce blood pressure 26 . In addition, variation in this gene was associated with blood pressure 27 , atherosclerosis 28 and cardiovascular disease endpoints 29 in candidate gene studies.
Two more regions showed suggestive evidence for association in our combined meta-analysis for plaque. The first region, near LDLR, is a particularly interesting candidate for subclinical atherosclerosis because of its role in familial hypercholesterolemia and its appearance in recent GWAS for lipid traits [30] [31] [32] [33] and myocardial infarction 14, 34 . Notably, the LDLR SNP recently reported to be associated with myocardial infarction (rs1122608) is located 38 kb away and is in modest linkage disequilibrium (r 2 = 0.2 in HapMap CEU) with the signal SNP (rs6511720) in our analysis, which also showed an association with CAD in the CARDIoGRAM consortium. The second region was in the vicinity of LRIG1, which negatively regulates growth factor signaling and is involved in the regulation of epidermal stem cell quiescence.
Notably, we found three loci (APOC1, PIK3CG and EDNRA) that were associated with all three carotid phenotypes. Among these, the EDNRA locus was also significantly associated with coronary artery disease in the recent large meta-analysis by the CARDIoGRAM consortium. These associations may provide important insights into the pathophysiological mechanisms relating the genes to atherosclerosis and subsequent coronary artery disease. In particular, the concordance of association with SNPs in EDNRA with both carotid plaque and coronary heart disease suggests a common etiology for subclinical and clinically apparent disease that warrants further investigation. Figure 5 Forest plots for plaque SNP associations. Plots show the studyspecific association estimates (odds ratios) and 95% confidence intervals for the nine discovery and three second-stage studies (listed in italics) presented as bars. The association estimate and confidence interval for the meta-analysis combining the discovery and second-stage results are shown as a diamond. Blank spaces indicate occasions in which a particular study was not able to provide results for a given SNP. Figure 4 Forest plots for common cIMT SNP associations. Plots show the study-specific association estimates (β) and 95% confidence intervals for the nine discovery and six second-stage studies (listed in italics) presented as bars. The scale is in ln(cIMT). The association estimate and confidence interval for the meta-analysis combining the discovery and second-stage results are shown as a diamond. Blank spaces indicate occasions in which a particular study was not able to provide results for a given SNP. 9 4 4 VOLUME 43 | NUMBER 10 | OCTOBER 2011 Nature GeNetics
A r t i c l e s
The strengths of the current study include the large sample size, the population-based designs, the collaboratively designed pre-specified analysis plan and the high quality of both genotyping and phenotyping. Further, our ability to relate our findings to the outcome of CAD in a large independent meta-analysis provides important additional context to our results. These associations are unlikely to be caused by population stratification because the discovery sample was restricted to individuals of European ancestry and was also investigated for global latent population substructure.
The study also has limitations. A single cross-sectional IMT assessment was used in all studies, and ultrasound protocols varied across the participating studies. For example, the plaque definition included the presence of any plaque in most studies but included stenosis >25% in others. The heterogeneity of measurement techniques may have compromised our ability to detect small associations. Despite this heterogeneity, the ability to detect consistent genetic associations for several carotid measures suggests that additional signals may be discovered in future studies using a larger sample size or a higher resolution technique, such as magnetic resonance imaging. Further, few studies had internal cIMT measures, as these measures are more difficult to obtain than common cIMT measurements, and this therefore limited our ability to discover associations with this phenotype. Although our sample size was reasonably large, we still had limited power to detect associations with small effect sizes. Genome-wide association studies are known for revealing associations with common variants and may miss rare variants not covered by the commercial genotyping arrays. For instance, the sparse coverage of the APOC1 and LDLR gene regions resulted in varying imputation quality and a lower effective sample size for the analysis of these two regions.
Because we did not conduct follow-up fine mapping of the results and because some SNPs were distant from known genes, it is likely that the identified SNPs are not causal variants, but, instead, may be in linkage disequilibrium with variants that were not analyzed. Because some of our associations attained genome-wide significant P values only in the combined meta-analysis, confirmation of our findings in other populations and further exploration of these genomic regions with dense genotyping, expression and translational studies will be required to better understand the role of these genes in subclinical atherosclerotic disease.
In summary, our meta-analysis of GWAS data from nine community-based studies has revealed five new loci for common cIMT and plaque. These loci implicate low-density lipoprotein metabolism (APOC1), endothelial dysfunction (EDNRA), platelet biology (PIK3CG) and telomere maintenance (PINX1) as biological traits associated with subclinical atherosclerosis. Two of our identified loci were also associated with coronary artery disease in the recent large meta-analysis by the CARDIoGRAM consortium. Exploring the molecular, cellular and clinical consequences of genetic variation at these loci may yield new insights into the pathophysiology of clinical and subclinical cardiovascular disease.
URLs. METAL, http://www.sph.umich.edu/csg/abecasis/Metal/. The Erasmus Rucphen Family Study was supported by grants from The Netherlands Organisation for Scientific Research, Erasmus Medical Center and the Centre for Medical Systems Biology (CMSB). We are grateful to all study participants and their relatives, the general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for the supervision of the laboratory work and P. Snijders for his help in data collection. Carotid artery phenotypes. Each study evaluated the carotid arteries with high-resolution B-mode ultrasonography using previously described reading protocols. For these analyses, we used data from the baseline examination or the first examination in which carotid ultrasonography was obtained. Our primary analysis concerned the common carotid artery using the intima-media thickness, typically summarized as the mean of the maximum of several measurements. For most studies, this was an average of multiple measurements from both the left and right arteries. All studies measured the far wall and several also included the near wall. We also examined the atherosclerotic thickening of the carotid artery wall, defined in seven of the nine studies by either the presence of plaque or the proxy measure of stenosis >25%. Secondary analyses considered the internal cIMT, which was characterized in three of the nine studies. As with the common carotid analyses, we used the mean of the maximal measurements from the near and far walls of the internal carotid arteries on both the left and right sides, which summarized the 1-12 measurements taken per participant. Specific details for each study's ultrasound, reading and plaque definition protocols are provided in the Supplementary Note.
METHODS
Methods
Genotyping and imputation. The nine studies in these analyses used commercial genotyping platforms available from Illumina or Affymetrix. Each study performed genotyping quality control checks and imputed the approximately 2.5 million polymorphic autosomal SNPs described in the HapMap CEU population for each participant using available imputation methods. Details of per-study genotyping, imputation and quality control procedures are available in the Supplementary Note.
Statistical analysis within studies. Each study independently implemented a predefined GWAS analysis plan. For the continuous measures of common and internal cIMT, we evaluated cross-sectional associations of ln(IMT) and genetic variation using linear regression models (or linear mixed effects models in the Amish, FHS and ERF data to account for family relatedness). For each of the 2.5 million SNPs, each study fit additive genetic models regressing trait on genotype dosage (0-2 copies of the variant allele). For the dichotomous outcome of plaque, each study used logistic regression models (or general estimating equations clustering on family to account for familial correlations). In our primary analyses, all studies were adjusted for age and sex. Some studies made additional adjustments, including adjusting for study site, familial structure or for whether the DNA had been whole-genome amplified or not. Additional details of the statistical analyses are available in the Supplementary Note.
Discovery meta-analysis. We conducted a meta-analysis of regression estimates and standard errors using an inverse-variance weighting approach as implemented in METAL (see URLs). After verification of strand alignment across studies and after quality control, filtering and imputation within each study, we restricted our meta-analysis to autosomal SNPs that were reported in at least two studies and had an average minor allele frequency of at least 1%. Prior to the meta-analysis, we calculated a genomic inflation factor (λ GC ) for each study to screen for cryptic population substructure or undiagnosed irregularities that might have inflated the test statistics. The inflations were low, with λ GC being below 1.09 in all studies. We applied 'genomic control' to each study whose genomic inflation factor was greater than 1.00 by multiplying all of the standard errors by the square root of the study-specific λ GC . For cIMT, we expressed the association of each SNP and ln(IMT) as the regression slope (β), its standard error (s.e.m. (β)) and a corresponding P value.
For the presence of plaque, we calculated a meta-analysis log odds ratio, 95% confidence interval and P value. In this case, the odds ratio represents the increase or decrease in the odds of plaque for each additional copy of the SNP's coded allele. Standardized gene and SNP annotations were created using a PERL program 36 . For follow up, we decided a priori on a significance threshold of P < 4 × 10 −7 , which corresponds to not more than one expected false positive finding over 2.5 million tests.
Second-stage meta-analysis. Second-stage samples were drawn from several external studies with available genetic data and measures of cIMT (six studies) or plaque (three studies). We provided each collaborating second-stage study with a list of all SNPs that attained genome-wide significant P values for common cIMT, internal cIMT or plaque and combined the results from these studies using a fixed-effects meta-analysis as described above.
Combined meta-analysis. Finally, we combined the results from the discovery and second-stage analyses using inverse-variance weighting, as described above, and considered SNPs with P < 5 × 10 −8 as genome-wide significant. 
